JNJ Stock Johnson & Johnson - Complete Overview
Nyse / Pharmaceutical Products / Healthcare / JNJ Stock
|Avg Daily Volume||7.57M|
JOHNSON & JOHNSON (JNJ) OVERVIEW
JNJ stock is a pharmaceutical products company traded on Nyse. It is valued at 348.54B US dollars. There are 2.68B shares outstanding which Johnson & Johnson issued to investors. Volatility of the stock is LOW, and the daily volume is 15.28% stock on average. Johnson & Johnson is paying dividends with the latest yield of 2.60%. It brought investors a total return of 6.99% over the last 12 months. Johnson & Johnson stock is relatively expensive. It's P/E ratio is above the market average.
Is Geron Corporation's Stock Set to Sail or Sink?
Geron's fourth-quarter earnings release raises more questions than it answers.
Basic Guide To Successful Investing - Part I
My approach to investing.Understanding Free Cash Flow and its importance.Letting compound interest do much of the work for you.
3 Things In Biotech, March 17: Janssen's Bladder Breakthrough, MorphoSys' Alzheimer's Success, Halozyme's Early Results
Janssen scores a breakthrough in bladder cancer.MorphoSys and Roche announce supporting evidence for their Alzheimer's study.Halozyme highlights preclinical studies at AACR.
Is Johnson & Johnson a Buy?
The case for -- and against -- the healthcare giant.
Johnson & Johnson: A Dividend King For Strong Returns
Johnson & Johnson is a diversified, stable company.Johnson & Johnson has a solid growth outlook, thanks to a strong pharmaceutical pipeline, and industry tailwinds.Shares of Johnson & Johnson will lik
Johnson & Johnson says Platinum Equity has offered to buy LifeScan for $2.1 billion
Johnson & Johnson said Friday it has received a binding offer from Platinum Equity to acquire its LifeScan business for about $2.1 billion. LifeScan is a blood glucose monitoring system with 2017 revenue of about $1.5 billion. If the offer is accepted by a June 15 deadline, the company expects to close the deal before year-end. Shares were flat in premarket trade, but have gained 3.8% in the last 12 months, while the S&P 500 has gained 15%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|Price to Earnings||270.65||67.47||84.09||29.94|
|Price to Book Value||5.79||3.93||4.63||3.52|
|Price to Sales||4.56||3.57||4.30||3.32|
|Return on Equity||1.90%||16.58%||22.79%||15.25%|
|Return on Assets||0.90%||4.83%||6.76%||5.67%|